These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of the mouse mammary tumor virus long terminal repeat open reading frame promotes tumorigenic potential of hyperplastic mouse mammary epithelial cells. Mukhopadhyay R; Medina D; Butel JS Virology; 1995 Aug; 211(1):74-93. PubMed ID: 7645239 [TBL] [Abstract][Full Text] [Related]
3. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; BisarĂ² B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
4. De-regulation of endogenous retrotransposons in mouse mammary carcinomas of diverse etiologies. Asch BB; Asch HL; Stoler DL; Anderson GR Int J Cancer; 1993 Jul; 54(5):813-9. PubMed ID: 8392034 [TBL] [Abstract][Full Text] [Related]
5. Human endogenous retrovirus K does not encode mouse mammary tumor virus-related antigens in human breast carcinomas. Vogetseder W; Denner J; Boller K; Kurth R; Dierich MP AIDS Res Hum Retroviruses; 1995 Jul; 11(7):869-72. PubMed ID: 7546915 [No Abstract] [Full Text] [Related]
6. MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Callahan R; Smith GH Oncogene; 2000 Feb; 19(8):992-1001. PubMed ID: 10713682 [TBL] [Abstract][Full Text] [Related]
7. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676 [TBL] [Abstract][Full Text] [Related]
8. Neoplastic transformation of porcine mammary epithelial cells in vitro and tumor formation in vivo. Rowson-Hodel AR; Manjarin R; Trott JF; Cardiff RD; Borowsky AD; Hovey RC BMC Cancer; 2015 Jul; 15():562. PubMed ID: 26228788 [TBL] [Abstract][Full Text] [Related]
9. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential. Drobysheva D; Smith BA; McDowell M; Guillen KP; Ekiz HA; Welm BE Breast Cancer Res; 2015 Oct; 17(1):132. PubMed ID: 26429062 [TBL] [Abstract][Full Text] [Related]
10. Expression of the retrotransposons, intracisternal A-particles, during neoplastic progression of mouse mammary epithelium analyzed with a monoclonal antibody. Asch BB; Asch HL Cancer Res; 1990 Apr; 50(8):2404-10. PubMed ID: 2156618 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor alpha and mouse models of human breast cancer. Humphreys RC; Hennighausen L Oncogene; 2000 Feb; 19(8):1085-91. PubMed ID: 10713694 [TBL] [Abstract][Full Text] [Related]
12. Mouse mammary tumor virus: new tumor virus or just a rumor virus? Brower V J Natl Cancer Inst; 2009 Mar; 101(5):293-5. PubMed ID: 19244171 [No Abstract] [Full Text] [Related]
13. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997 [TBL] [Abstract][Full Text] [Related]
14. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis. Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402 [TBL] [Abstract][Full Text] [Related]
15. Human mammary tumor virus in inflammatory breast cancer. Pogo BG; Holland JF; Levine PH Cancer; 2010 Jun; 116(11 Suppl):2741-4. PubMed ID: 20503403 [TBL] [Abstract][Full Text] [Related]
16. TUMOR VIRUS INFECTION IN DDO MICE. II. IN VITRO AND IN VIVO ANALYSES OF EXTRACT FROM DDO MOUSE MAMMARY TUMOR: ITS RELATION TO POLYOMA VIRUS. KUMEGAWA M Gan; 1964 Apr; 55():99-107. PubMed ID: 14157663 [No Abstract] [Full Text] [Related]
17. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice. Zhang H; Kuang SQ; Liao L; Zhou S; Xu J Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215 [TBL] [Abstract][Full Text] [Related]
18. The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells. Boyle ST; Ingman WV; Poltavets V; Faulkner JW; Whitfield RJ; McColl SR; Kochetkova M Oncogene; 2016 Jan; 35(1):105-15. PubMed ID: 25772241 [TBL] [Abstract][Full Text] [Related]
19. Mammary tumors induced by polyomavirus. Fluck MM; Haslam SZ Breast Cancer Res Treat; 1996; 39(1):45-56. PubMed ID: 8738605 [TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells and cells of origin in MMTV-Her2/neu-induced mammary tumorigenesis. Lo PK; Chen H Oncogene; 2013 Mar; 32(10):1338-40. PubMed ID: 23045276 [No Abstract] [Full Text] [Related] [Next] [New Search]